The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.

China's economy tsar, Vice Premier He Lifeng, sought to reassure foreign CEOs of the country's business potential, describing ...

With over 35 years in China, Vantive has operated three manufacturing facilities in Suzhou, Jiangsu province, Guangzhou, ...

Beijing is fostering the growth of China’s commercial space industry in a bid to narrow a space-race gap with the U.S.

While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to warrant that title regardless of what's transpired in 2025. Among them are CRISPR ...

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

Moves by the Dow Jones Industrial Average and other major indexes improved ever so slightly Friday afternoon. The Nasdaq ...

Wang Xing, CEO of China's largest food delivery firm Meituan , said on Friday in a post-earnings call that the company is ...

Biotech stocks are among the few industry groups producing breakouts and buyable stocks in an uncertain market. Vertex stock ...

Expedition Therapeutics, a new startup hoping to source the best therapies being developed in China and bring them stateside, ...

"They have conquered every market they've engaged," Huang said of Huawei.

Top foreign CEOs will flock to China to attend the annual China Development Forum in Beijing, Reuters reported on Monday.